Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Oosthuizen is active.

Publication


Featured researches published by P. Oosthuizen.


Acta Psychiatrica Scandinavica | 2005

Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country

P. Oosthuizen; Robin Emsley; Natasha Keyter; D. J. H. Niehaus; Liezl Koen

Objective:  To investigate the association between duration of untreated psychosis (DUP) and treatment outcome in a sample of subjects from a developing country.


The International Journal of Neuropsychopharmacology | 1999

Treatment of schizophrenia in low-income countries.

Robin Emsley; P. Oosthuizen; Andrè F. Joubert; Susan Hawkridge; Dan J. Stein

The introduction of the novel antipsychotics has had a major impact upon the treatment of schizophrenia. However, the greater acquisition costs of these drugs puts them beyond the reach of large sectors of the worlds population. Consequently, the gap between the levels of care in high-income and low-income countries is likely to widen even further. Co-ordinated global action is necessary to ensure greater accessibility of these drugs. Cost-effectiveness studies in low-income countries need to be undertaken. The considerable evidence for improved safety and efficacy of low-dose compared to high-dose classical antipsychotics offers an alternative that could be implemented immediately in low-income countries.


Psychopathology | 2004

A Culture-Bound Syndrome ‘Amafufunyana’ and a Culture-Specific Event ‘Ukuthwasa’: Differentiated by a Family History of Schizophrenia and other Psychiatric Disorders

Dana Niehaus; P. Oosthuizen; Christine Lochner; Robin Emsley; Esme Jordaan; N.I. Mbanga; Natasha Keyter; Claudine Laurent; J.-F. Deleuze; Dan J. Stein

Background: ‘Amafufunyana’ and ‘ukuthwasa’ are two culture-specific descriptive terms used by Xhosa traditional healers to explain aberrant behavioral and psychological phenomena. Some overlap between these conditions and schizophrenia (DSM-IV) is apparent. The aim of this study was to determine the extent to which amafufunyana and ukuthwasa were used as cultural explanatory models by traditional healers for DSM-IV-defined schizophrenia and whether there were significant phenomenological differences in schizophrenia symptoms in patients with the diagnosis of amafufunyana rather than ukuthwasa. Sampling and Methods: Xhosa patients with schizophrenia underwent a structured clinical diagnostic interview (Diagnostic Interview for Genetic Studies). The use of traditional diagnostic and treatment methods was assessed by structured open-ended interviewer-rated questions. The sample was then stratified for the presence/absence of a past/current diagnosis of amafufunyana and/or ukuthwasa. The clinical parameters were compared across groups by means of the χ2 or Student t tests. Results: 247 adult subjects participated in the study. 106 (53%) patients reported a previous diagnosis of amafufunyana, and 9 (4.5%) reported a diagnosis of ukuthwasa. A family history of schizophrenia (p = 0.004) or any psychiatric disorder (p = 0.008) was more common in the ukuthwasa group. Subjects with a primary diagnosis other than amafufunyana or ukuthwasa were more likely to be married (p = 0.004), to have a history of stressor(s) prior to illness onset (p = 0.026), to be from a rural environment (p = 0.007) or to have a history of cannabis abuse/dependency (p = 0.015). Conclusion: The culture-bound syndrome amafufunyana and the culture-specific phenomenon of ukuthwasa are both used to explain symptoms in patients with schizophrenia (DSM-IV). Identification of cases as amafufunyana and ukuthwasa may correlate with a distinction between familial and sporadic cases of schizophrenia. Whether the positive connotations associated with ukuthwasa, as opposed to the more negative connotations associated with amafufunyana, hold any implications for the treatment or prognosis of schizophrenia remains to be clarified.


European Psychiatry | 2011

Subjective awareness of tardive dyskinesia and insight in schizophrenia

Robin Emsley; D. J. H. Niehaus; P. Oosthuizen; Liezl Koen; Bonginkosi Chiliza; D. Fincham

BACKGROUND Lack of awareness of tardive dyskinesia (TD) and poor insight into mental illness are common in schizophrenia, raising the possibility that these phenomena are manifestations of a common underlying dysfunction. METHODS We investigated relationships between low awareness of TD and poor insight into mental illness in 130 patients with schizophrenia and TD. We also examined selected demographic and clinical correlates of these two phenomena. RESULTS Sixty-six (51%) patients had no or low awareness of TD and 94 (72%) had at least mild impairment of insight into their mental illness. Low awareness of TD was not significantly correlated with greater impairment of insight into mental illness. Regression analyses indicated that the Positive and Negative Syndrome Scale (PANSS) disorganised factor (β=0.72, t=11.88, p<0.01) accounted for 52% of the variance in insight into mental illness (adjusted R(2)=0.55) (F[2, 127]=81.00, p<0.01) and the Extrapyramidal Symptom Rating Scale (ESRS) dyskinesia subscale score (β=0.47, t=6.80, p<0.01), PANSS disorganised factor (β=-0.26, t=-3.73, p<0.01), and ESRS parkinsonism subscale score (β=0.31, t=4.55, p<0.01) together accounted for 37% of the variance in awareness of TD (adjusted R(2)=0.37) (F[3, 126]=26.87, p<0.01). CONCLUSION The two phenomena appear to be dissociated, and may be domain-specific.


American Journal of Psychiatry | 2002

Randomized, Placebo-Controlled Study of Ethyl-Eicosapentaenoic Acid as Supplemental Treatment in Schizophrenia

Robin Emsley; Christo Myburgh; P. Oosthuizen; Susan J. van Rensburg


South African Medical Journal | 2007

Anxiety, depression, health attitudes and coping strategies in doctors and teachers in a Cape Town setting

H van der Bijl; P. Oosthuizen


Schizophrenia Research | 2006

0395 REMISSION IN SCHIZOPHRENIA: RESULTS FROM A 12-MONTH ANALYSIS OF LONG-ACTING RISPERIDONE IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS

Robin Emsley; P. Oosthuizen; Liezl Koen; Dana Niehaus; A. Lex; Rossella Medori


South African Medical Journal | 2007

Changing the course of schizophrenia - predictors of treatment outcome revisited

Robin Emsley; P. Oosthuizen; D. J. H. Niehaus; Liezl Koen; Bonginkosi Chiliza


Schizophrenia Research | 2003

Treatment with low-dose haloperidol does not protect against tardive dyskinesia

P. Oosthuizen; Robin Emsley; J.S. Maritz; Jadri Turner; Natasha Keyter


South African Medical Journal | 2007

Longer duration of breastfeeding associated with reduced risk of developing schizophrenia

M.S. Hartog; P. Oosthuizen; Robin Emsley

Collaboration


Dive into the P. Oosthuizen's collaboration.

Top Co-Authors

Avatar

Robin Emsley

Stellenbosch University

View shared research outputs
Top Co-Authors

Avatar

Liezl Koen

Stellenbosch University

View shared research outputs
Top Co-Authors

Avatar

Dan J. Stein

University of Cape Town

View shared research outputs
Top Co-Authors

Avatar

Dana Niehaus

Stellenbosch University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Esme Jordaan

University of the Western Cape

View shared research outputs
Top Co-Authors

Avatar

M.S. Hartog

Stellenbosch University

View shared research outputs
Researchain Logo
Decentralizing Knowledge